Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
2.
Clin Rheumatol ; 17(5): 393-4, 1998.
Article in English | MEDLINE | ID: mdl-9805185

ABSTRACT

Candida arthritis is infrequent in patients who are not intravenous drug users. We describe a patient who was not an intravenous drug user and without other predisposing factors who developed knee arthritis caused by Candida albicans. We believe that this is the first report of such a case.


Subject(s)
Arthritis, Infectious/microbiology , Candida albicans/isolation & purification , Candidiasis/complications , Immunocompetence , Aged , Antifungal Agents/therapeutic use , Arthritis, Infectious/complications , Arthritis, Infectious/drug therapy , Candida albicans/drug effects , Candidiasis/drug therapy , Fluconazole/therapeutic use , Humans , Knee Joint/microbiology , Male
3.
Clin Rheumatol ; 11(1): 116-9, 1992 Mar.
Article in English | MEDLINE | ID: mdl-1582110

ABSTRACT

We report a case of a 53-year-old woman diagnosed of systemic sclerosis. She underwent an episode of pulmonary haemorrhage, characterized by haemoptysis, sudden anaemization, and bilateral alveolar infiltration during her hospitalization, which was resolved with steroid treatment. Subsequently, she developed a focal necrotizing glomerulonephritis. After searching in the literature, we have found only three cases of systemic sclerosis associated with pulmonary haemorrhage. We discuss the etiopathogenesis of this association and stress the importance of early steroid therapy.


Subject(s)
Glomerulosclerosis, Focal Segmental/complications , Hemorrhage/complications , Lung Diseases/complications , Scleroderma, Systemic/complications , Female , Glomerulosclerosis, Focal Segmental/drug therapy , Hemorrhage/drug therapy , Humans , Lung Diseases/drug therapy , Middle Aged , Steroids/therapeutic use
4.
Semin Arthritis Rheum ; 15(3): 200-12, 1986 Feb.
Article in English | MEDLINE | ID: mdl-3961509

ABSTRACT

Thirty-two toxic oil syndrome (TOS) patients were selected because they presented with scleroderma-like changes and were observed during the first 36 months of evolution of the disease. Initially, these patients presented with a noncardiogenic pulmonary edema, eosinophilia, arthralgia/arthritis, peripheral edema, and myositis. Histologic investigations showed a widespread chronic interstitial infiltrate with lymphocytic vasculitis. They subsequently developed peripheral neuropathy, joint contractures, scleroderma-like changes, Raynaud phenomenon, pulmonary hypertension, sicca syndrome, and liver disease. Biopsy studies during this stage showed fibrosis and obliterating arteriopathy. Late features of TOS are musculoskeletal pain, cramps, livedo reticularis, carpal tunnel syndrome, and digital tuft changes. TOS is a new chemically induced scleroderma-like syndrome with features overlapping those of eosinophilic fasciitis, systemic sclerosis, and forms of localized scleroderma.


Subject(s)
Brassica , Food Contamination , Oils/poisoning , Scleroderma, Systemic/chemically induced , Adolescent , Adult , Aged , Child , Child, Preschool , Eosinophilia/chemically induced , Fasciitis/chemically induced , Female , Gastrointestinal Diseases/chemically induced , Humans , Joint Diseases/chemically induced , Male , Middle Aged , Neuromuscular Diseases/chemically induced , Pulmonary Edema/chemically induced , Raynaud Disease/chemically induced , Scleroderma, Localized/chemically induced , Scleroderma, Systemic/pathology , Scleroderma, Systemic/physiopathology , Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL
...